Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 11.10.2009

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
11.10.09Onyx Pharmaceuticals Announces Investor Teleconference and Webcast86EMERYVILLE, Calif., Oct. 11 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today announced that it will webcast a teleconference with management to provide a general business update on...
► Artikel lesen
11.10.09Rentrak Announces Box Office Numbers for Weekend of October 9, 200911LOS ANGELES, Oct. 11 /PRNewswire-FirstCall/ -- Rentrak Corporation , today announced the weekend theatrical box office estimates for the weekend period of October 9 through October 11, 2009...
► Artikel lesen
11.10.09Dilon Diagnostics Joins Forces With Philips for Women's Health Solutions / Molecular Breast Imaging/Breast-Specific Gamma Imaging to complement Philips total women's health solutions offering in Europe and Middle East30NEWPORT NEWS, Va., Oct. 11 /PRNewswire/ -- Dilon Diagnostics, the leader in molecular breast imaging (MBI) also known as Breast-Specific Gamma Imaging (BSGI) and Philips , today announce that...
► Artikel lesen
11.10.09Ultra-mobile PC grabs top honor at Global Sources Electronics Design Awards8Winning CCTV products, digital photo frames, GPS, in-car entertainment, mobile phones, portable media and portable PCs to be showcased at China Sourcing Fair: Electronics & Components...
► Artikel lesen
11.10.09Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix6PHOENIX and SAN CARLOS, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Nektar Therapeutics presented topline data today from its Phase 2 clinical trial of oral NKTR-118 at the American Academy of...
► Artikel lesen